Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keck School of Medicine

Division of University of Southern California
www.usc.edu/schools/medicine/

Latest From Keck School of Medicine

Tech Transfer Roundup: Amgen Teams With MD Anderson To Accelerate Early-Stage Cancer Candidates

In a busy month, MD Anderson also partners with Ipsen on an unspecified cancer drug and licenses poziotinib IP to Spectrum. Using IP from UCLA, Bloom launches with focus on neuroprotective epilepsy therapies.

Deals Intellectual Property

Optogenetics: Start-Ups Head For The Light

Optogenetics – technology to control neurons with light – has swept through basic neuroscience research. Efforts to commercialize optogenetics are complex, but a spunky group of start-ups plan to develop therapies using the technology.

BioPharmaceutical

ASCO 2014: Oncology Companion Diagnostics Market Poised For Growth

The market for oncology companion diagnostics is poised for significant growth, according to Sagient Research Systems. Reporting from ASCO 2014, Sagient analysts highlight key presentations on companion diagnostics, provide information on oncology diagnostic market trends, and note movement in clinical trials toward more adaptive designs with smaller patient numbers and incorporation of companion diagnostics.

Medical Device Innovation

Women's Health: Promising Advances, But Challenges Persist

The field of women's health is one of the most progressive medical technology sectors in the US, driven by the aging population, diagnostic advances in deadly ovarian and colorectal cancer, and medical device innovations in gynecologic and urogynecologic disease management, including a shift toward minimally invasive surgery (MIS) techniques and robotics and the addition of a new field: bariatric gynecology. At the WH 2.0 Consensus Conference on Women's Health, held recently in Los Angeles, experts agreed that advances in medical technology are promising better detection and treatment of a host of diseases impacting both premenopausal and postmenopausal women. However, challenges remain in managing obesity-related disease and improving screening for often-undetected cancers in women.

Medical Device
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register